Phytomedicine

雜志介紹

Phytomedicine雜志介紹

《Phytomedicine》是一本以German為主的未開放獲取國際優(yōu)秀期刊，中文名稱植物藥，本刊主要出版、報(bào)道醫(yī)學(xué)-CHEMISTRY, MEDICINAL領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為6.7，最新CiteScore 指數(shù)為10.3。

本刊近期中國學(xué)者發(fā)表的論文主要有：

• T52 attenuates oncogenic STAT3 signaling and suppresses osteosarcoma

  Author: Tian, Liru; Li, Chuan; Xiang, Limin; Zeng, Jia; Chen, Shuqing; Guo, Weimin; Chen, Shulin; Wang, Yihai; He, Xiangjiu; Su, Peiqiang; Xu, Caixia

• Cajanin stilbene acid: A direct inhibitor of colistin resistance protein MCR-1 that restores the efficacy of polymyxin B against resistant Gram-negative bacteria

  Author: Jia, Yue; Liu, Juzhao; Yang, Qin; Zhang, Wanjiang; Efferth, Thomas; Liu, Siguo; Hua, Xin

• Differences in p38-STAT3-S100A11 signaling after the administration of aristolochic acid I and IVa may account for the disparity in their nephrotoxicity

  Author: Xian, Zhong; Tian, Jingzhuo; Zhao, Yong; Yi, Yan; Li, Chunying; Han, Jiayin; Zhang, Yushi; Wang, Yuan; Wang, Lianmei; Liu, Suyan; Pan, Chen; Liu, Chenyue; Wang, Dunfang; Meng, Jing; Tang, Xuan; Wang, Fang; Liang, Aihua

• Panax notoginseng saponins normalises tumour blood vessels by inhibiting EphA2 gene expression to modulate the tumour microenvironment of breast cancer

  Author: Xia, Linying; Liu, XianLi; Mao, Weiye; Guo, Yingxue; Huang, Jie; Hu, Yingnan; Jin, Lu; Liu, Xia; Fu, Huiying; Du, Yueguang; Shou, Qiyang

英文介紹

Phytomedicine雜志英文介紹

Phytomedicine is primarily a therapy-oriented Journal. Phytomedicine publishes innovative studies on efficacy, safety, quality and mechanisms of action of specified plant extracts, phytopharmaceuticals and their isolated constituents. This includes clinical, pharmacological, pharmacokinetic, and toxicological studies of specified herbal medicinal products, herbal preparations and purified compounds which have a defined and consistent quality assuring reproducible pharmacological activity.

Phytomedicine was founded in 1994 to focus and stimulate research in this particular field and to set internationally accepted scientific standards for pharmacological studies, proof of clinical efficacy and safety of phytomedicines.